Pottathuparambil,Robin Coyne,Jack Allred,Jeffrey Lynch,William Natoli,Vincent Low-Latency FPGA Based Financial Data Feed Handler. IEEE Computer Society 93-96 2011 Ultes-Nitsche,Ulrich Allred,Joël k-Counting Automata. Austrian Computer Society 282 37-50 2011 Allred,AdamF. Wu,Guang Wulan,Tuya Fischer,KaelF. Holbrook,MichaelR. Tesh,RobertB. Wang,David VIPR: A probabilistic algorithm for analysis of microbial detection microarrays. BMC Bioinformatics 11 384 2010 Allred,Jeffrey Coyne,Jack Lynch,William Natoli,Vincent Grecco,Joseph Morrissette,Joel Smith-Waterman implementation on a FSB-FPGA module using the Intel Accelerator Abstraction Layer. IEEE 1-4 2009 Allred,Jude Hasan,AhmadBilal Panichsakul,Saroch Pisano,William Gray,Peter Huang,Jyh Han,Richard Lawrence,Dale Mohseni,Kamran SensorFlock: an airborne wireless sensor network of micro-air vehicles. ACM 117-129 2007 Fiedler,W. Serve,H. Dohner,H. Schwittay,M. Ottmann,O.G. O'Farrell,A.M. Bello,C.L. Allred,R. Manning,W.C. Cherrington,J.M. Louie,S.G. Hong,W. Brega,N.M. Massimini,G. Scigalla,P. Berdel,W.E. Hossfeld,D.K. A phase 1 study of SU11248 in the treatment of patients with refractory or resistant acute myeloid leukemia (AML) or not amenable to conventional therapy for the disease Blood 105 986-993 2005 Fifteen patients with refractory AML were treated in a phase 1 study with SU11248, an oral kinase inhibitor of fms-like tyrosine kinase 3 (Flt3), Kit, vascular endothelial growth factor (VEGF), and platelet-derived growth factor (PDGF) receptors. Separate cohorts of patients received SU11248 for 4-week cycles followed by either a 2- or a 1-week rest period. At the starting dose level of 50 mg (n = 13), no dose-limiting toxicities were observed. The most frequent grade 2 toxicities were edema, fatigue, and oral ulcerations. Two fatal bleedings possibly related to the disease, one from a concomitant lung cancer and one cerebral bleeding, were observed. At the 75 mg dose level (n = 2), one case each of grade 4 fatigue, hypertension, and cardiac failure was observed, and this dose level was abandoned. All patients with FLT3 mutations (n = 4) had morphologic or partial responses compared with 2 of 10 evaluable patients with wild-type FLT3. Responses, although longer in patients with mutated Allred,SarahR. Liu,Yan Jagadeesh,Bharathi Algorithms for image database navigation and tuning of object selective neurons in the non-human primate. ACM 73 161 2004 Allred,DanielJ. Huang,Walter Krishnan,Venkatesh Yoo,Heejong Anderson,DavidV. An FPGA Implementation for a High Throughput Adaptive Filter Using Distributed Arithmetic. IEEE Computer Society 324-325 2004 Allred,TimothyM. Compliant Mechanism Suspensions 2003 Allred,J.C. Lyman,R.N. Kornack,T.W. Romalis,M.V. High-Sensitivity Atomic Magnetometer Unaffected by Spin-Exchange Relaxation \prl 89 130801-+ 2002 Anderson,DavidR. Allred,Ken Dennen,Kevin Roberts,Patrick Brown,WilliamR. Burroughs,EllisE. LeSueur,KennethG. Clardy,Tim Distributed Test Capability Using Infrared Scene Projector Technology. Springer 2074 550-557 2001 Allred,Daryl Lichtenstein,Yossi Preist,Chris Bennett,MichaelA. 0005,AjayGupta AGATHA: An Integrated Expert System to Test and Diagnose Complex Personal Computer Boards. AAAI 87-103 1991